JP2016527215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016527215A5 JP2016527215A5 JP2016524705A JP2016524705A JP2016527215A5 JP 2016527215 A5 JP2016527215 A5 JP 2016527215A5 JP 2016524705 A JP2016524705 A JP 2016524705A JP 2016524705 A JP2016524705 A JP 2016524705A JP 2016527215 A5 JP2016527215 A5 JP 2016527215A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- formula
- optionally substituted
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 38
- 229910052757 nitrogen Chemical group 0.000 claims 24
- 229910052717 sulfur Inorganic materials 0.000 claims 23
- 229910052760 oxygen Inorganic materials 0.000 claims 22
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 22
- 239000001301 oxygen Substances 0.000 claims 22
- 125000005842 heteroatoms Chemical group 0.000 claims 20
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 20
- 239000011593 sulfur Chemical group 0.000 claims 20
- 125000004429 atoms Chemical group 0.000 claims 18
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 18
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 11
- 125000005549 heteroarylene group Chemical group 0.000 claims 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 10
- 125000005651 substituted 1,4-phenylene group Chemical group 0.000 claims 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 7
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 125000004474 heteroalkylene group Chemical group 0.000 claims 3
- 150000002829 nitrogen Chemical group 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 3
- 125000005650 substituted phenylene group Chemical group 0.000 claims 3
- 125000004434 sulfur atoms Chemical group 0.000 claims 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- 206010011732 Cyst Diseases 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 230000001851 biosynthetic Effects 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000004404 heteroalkyl group Chemical group 0.000 claims 2
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- 206010060945 Bacterial infection Diseases 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000000295 complement Effects 0.000 claims 1
- 239000001963 growth media Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 0 COC(C(C(Nc(cc1)ccc1C(*)=O)=O)NC(c(cc1)ccc1NC(c(cc1)ccc1[N+]([O-])=O)=O)=O)C([Rn])=O Chemical compound COC(C(C(Nc(cc1)ccc1C(*)=O)=O)NC(c(cc1)ccc1NC(c(cc1)ccc1[N+]([O-])=O)=O)=O)C([Rn])=O 0.000 description 2
- WMLWGVVLDSEQNF-UHFFFAOYSA-N CC(C)Oc(c(NC(c(cc1)ccc1NC(C(C(C(N)=O)OC)NC(c(cc1)ccc1NC(c(cc1)ccc1[N+]([O-])=O)=O)=O)=O)=O)ccc1C(Nc(c(OC)c2)ccc2C(O)=O)=O)c1O Chemical compound CC(C)Oc(c(NC(c(cc1)ccc1NC(C(C(C(N)=O)OC)NC(c(cc1)ccc1NC(c(cc1)ccc1[N+]([O-])=O)=O)=O)=O)=O)ccc1C(Nc(c(OC)c2)ccc2C(O)=O)=O)c1O WMLWGVVLDSEQNF-UHFFFAOYSA-N 0.000 description 1
- NGSYXDCEERWVTK-UHFFFAOYSA-N CC(C)Oc(c(NC(c(cc1)ccc1NC(C(C(C(N)=O)OC)NC(c(cc1)ccc1NC(c(cc1)ccc1[N+]([O-])=O)=O)=O)=O)=O)ccc1C(Nc(cc2)ccc2C(O)=O)=O)c1O Chemical compound CC(C)Oc(c(NC(c(cc1)ccc1NC(C(C(C(N)=O)OC)NC(c(cc1)ccc1NC(c(cc1)ccc1[N+]([O-])=O)=O)=O)=O)=O)ccc1C(Nc(cc2)ccc2C(O)=O)=O)c1O NGSYXDCEERWVTK-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13003539.7 | 2013-07-12 | ||
EP13003539 | 2013-07-12 | ||
PCT/EP2014/001925 WO2015003816A2 (en) | 2013-07-12 | 2014-07-14 | Cystobactamides |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016527215A JP2016527215A (ja) | 2016-09-08 |
JP2016527215A5 true JP2016527215A5 (US07794700-20100914-C00152.png) | 2017-08-03 |
JP6730183B2 JP6730183B2 (ja) | 2020-07-29 |
Family
ID=48792948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016524705A Active JP6730183B2 (ja) | 2013-07-12 | 2014-07-14 | シストバクトアミド(Cystobactamides) |
Country Status (7)
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160145304A1 (en) | 2013-07-12 | 2016-05-26 | Helmholtz-Zentrum für Infektionsforschung GmbH | Cystobactamides |
GB201402277D0 (en) | 2014-02-10 | 2014-03-26 | Sentinel Oncology Ltd | Pharmaceutical compounds |
KR101747702B1 (ko) | 2014-05-15 | 2017-06-19 | 한국생명공학연구원 | 신규한 항균성 화합물 및 이의 용도 |
US10519099B2 (en) | 2014-11-26 | 2019-12-31 | Helmholtz-Zentrum für Infektionsforschung GmbH | Cystobactamides |
CN105712894A (zh) * | 2016-03-23 | 2016-06-29 | 叶芳 | 一种3-甲氧基-4-氨基苯甲酸及其制备方法 |
JP7037122B2 (ja) * | 2016-09-28 | 2022-03-16 | 日産化学株式会社 | ジアミンおよびその利用 |
JOP20200001A1 (ar) | 2017-07-11 | 2022-10-30 | Vertex Pharma | كاربوكسأميدات بوصفها معدلات لقنوات الصوديوم |
EP3655394B1 (en) | 2017-07-18 | 2023-11-22 | Technische Universität Berlin | Novel albicidin derivatives, their use and synthesis |
AU2018321152B2 (en) * | 2017-08-23 | 2023-07-06 | Helmholtz-Zentrum für Infektionsforschung GmbH | Novel cystobactamide derivatives |
BR112020003725A2 (pt) | 2017-10-06 | 2020-11-03 | Forma Therapeutics, Inc. | inibição da peptidase 30 específica de ubiquitina |
AU2019207608B2 (en) | 2018-01-10 | 2024-03-28 | Recurium Ip Holdings, Llc | Benzamide compounds |
AU2019222644B2 (en) | 2018-02-13 | 2021-04-01 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
CN112041311B (zh) | 2018-04-19 | 2023-10-03 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
JP7449242B2 (ja) | 2018-05-17 | 2024-03-13 | フォーマ セラピューティクス,インコーポレイテッド | ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物 |
EP4234030A3 (en) | 2018-07-13 | 2023-10-18 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
SI3860989T1 (sl) | 2018-10-05 | 2023-06-30 | Forma Therapeutics, Inc. | Kondenzirani pirolini,ki delujejo kot zaviralci ubikvitin-specifične proteaze (usp30) |
WO2020086556A1 (en) | 2018-10-24 | 2020-04-30 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
CA3145864A1 (en) | 2019-07-03 | 2021-01-07 | Sumitomo Dainippon Pharma Oncology, Inc. | Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof |
TW202128675A (zh) | 2019-12-06 | 2021-08-01 | 美商維泰克斯製藥公司 | 作為鈉通道調節劑之經取代四氫呋喃 |
PE20241335A1 (es) | 2021-06-04 | 2024-07-03 | Vertex Pharma | N-(hidroxialquil (hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio |
CN113563220B (zh) * | 2021-06-25 | 2023-08-29 | 华中农业大学 | 一种抗菌化合物及其应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525354A (en) * | 1983-09-14 | 1985-06-25 | University Of Hawaii | Antibiotic and process for the production thereof |
US7020622B1 (en) * | 1997-06-10 | 2006-03-28 | Linkshare Corporation | Transaction tracking, managing, assessment, and auditing data processing system and network |
FR2772025B1 (fr) | 1997-12-10 | 2000-03-03 | Guerbet Sa | Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique |
MXPA02010565A (es) * | 2000-04-28 | 2004-05-17 | Kosan Biosciences Inc | Produccion de policetidos. |
CA2413702A1 (en) | 2000-06-28 | 2002-01-03 | Teva Pharmaceuticals Industries Ltd. | Carvedilol |
AU2003286498A1 (en) * | 2002-10-18 | 2004-05-04 | Centre De Cooperation Internationale En Recherche Agronomique Pour Le Developpement (Cirad) | Complete biosynthetic gene set for biosynthesis of albicidin, resistance genes, and uses thereof |
WO2006109846A1 (ja) | 2005-04-06 | 2006-10-19 | Takeda Pharmaceutical Company Limited | トリアゾール誘導体およびその用途 |
US7758972B2 (en) * | 2006-09-26 | 2010-07-20 | Semiconductor Energy Laboratory Co., Ltd. | Stilbene derivative, light emitting element, light emitting device, and electronic appliance |
JP5379965B2 (ja) * | 2006-09-26 | 2013-12-25 | 株式会社半導体エネルギー研究所 | スチルベン誘導体、発光素子および発光装置 |
US8236983B2 (en) * | 2008-03-13 | 2012-08-07 | Board Of Regents, The University Of Texas System | Composition and method for the treatment of diseases affected by apoptosis |
US8618324B2 (en) * | 2007-03-13 | 2013-12-31 | Board Of Regents, The University Of Texas System | Composition and method for making oligo-benzamide compounds |
WO2013078277A1 (en) * | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Oligo-benzamide compounds and their use in treating cancers |
EP2956437B1 (en) * | 2013-02-15 | 2023-05-10 | Technische Universität Berlin | Albicidin derivatives for the treatment of bacterial infections |
US20160145304A1 (en) * | 2013-07-12 | 2016-05-26 | Helmholtz-Zentrum für Infektionsforschung GmbH | Cystobactamides |
KR101747702B1 (ko) | 2014-05-15 | 2017-06-19 | 한국생명공학연구원 | 신규한 항균성 화합물 및 이의 용도 |
US10519099B2 (en) * | 2014-11-26 | 2019-12-31 | Helmholtz-Zentrum für Infektionsforschung GmbH | Cystobactamides |
-
2014
- 2014-07-14 US US14/904,654 patent/US20160145304A1/en not_active Abandoned
- 2014-07-14 EP EP14747296.3A patent/EP3019615B1/en active Active
- 2014-07-14 WO PCT/EP2014/001925 patent/WO2015003816A2/en active Application Filing
- 2014-07-14 CN CN201480050439.3A patent/CN105793424B/zh active Active
- 2014-07-14 JP JP2016524705A patent/JP6730183B2/ja active Active
- 2014-07-14 AU AU2014289663A patent/AU2014289663B2/en active Active
- 2014-07-14 CA CA2917767A patent/CA2917767C/en active Active
-
2018
- 2018-07-23 US US16/042,753 patent/US10793600B2/en active Active
-
2020
- 2020-06-10 US US16/897,497 patent/US11225503B2/en active Active